Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.

Kianpour M, Huang CW, Vejvisithsakul PP, Wang JY, Li CF, Shiao MS, Pan CT, Shiue YL

Open source

DOI
10.1016/j.ijbiomac.2023.125510
Published
2023 Aug 1
Container
International journal of biological macromolecules
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 2/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijbiomac.2023.125510,
  title = {Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.},
  author = {Kianpour M and Huang CW and Vejvisithsakul PP and Wang JY and Li CF and Shiao MS and Pan CT and Shiue YL},
  year = {2023},
  journal = {International journal of biological macromolecules},
  doi = {10.1016/j.ijbiomac.2023.125510},
  url = {https://doi.org/10.1016/j.ijbiomac.2023.125510}
}

RIS

TY  - JOUR
TI  - Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.
AU  - Kianpour M
AU  - Huang CW
AU  - Vejvisithsakul PP
AU  - Wang JY
AU  - Li CF
AU  - Shiao MS
AU  - Pan CT
AU  - Shiue YL
PY  - 2023
JO  - International journal of biological macromolecules
DO  - 10.1016/j.ijbiomac.2023.125510
UR  - https://doi.org/10.1016/j.ijbiomac.2023.125510
ER  - 

APA

M, K., CW, H., PP, V., JY, W., CF, L., MS, S., CT, P., & YL, S. (2023). Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.. International journal of biological macromolecules. https://doi.org/10.1016/j.ijbiomac.2023.125510

Source records